Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP305376.RA6mCu8FmG4UzXEK7S5qLt98SjuS3x_ghFAmC4n56ntyY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP305376.RA6mCu8FmG4UzXEK7S5qLt98SjuS3x_ghFAmC4n56ntyY130_assertion type Assertion NP305376.RA6mCu8FmG4UzXEK7S5qLt98SjuS3x_ghFAmC4n56ntyY130_head.
- NP305376.RA6mCu8FmG4UzXEK7S5qLt98SjuS3x_ghFAmC4n56ntyY130_assertion description "[Interactions between MAGE-A4, LAGE1 and NY-ESO1 and their significant clinical consequences introduce these CTAs as appropriate targets for a polyvalent cancer vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP305376.RA6mCu8FmG4UzXEK7S5qLt98SjuS3x_ghFAmC4n56ntyY130_provenance.
- NP305376.RA6mCu8FmG4UzXEK7S5qLt98SjuS3x_ghFAmC4n56ntyY130_assertion evidence source_evidence_literature NP305376.RA6mCu8FmG4UzXEK7S5qLt98SjuS3x_ghFAmC4n56ntyY130_provenance.
- NP305376.RA6mCu8FmG4UzXEK7S5qLt98SjuS3x_ghFAmC4n56ntyY130_assertion SIO_000772 21613820 NP305376.RA6mCu8FmG4UzXEK7S5qLt98SjuS3x_ghFAmC4n56ntyY130_provenance.
- NP305376.RA6mCu8FmG4UzXEK7S5qLt98SjuS3x_ghFAmC4n56ntyY130_assertion wasDerivedFrom befree-20140225 NP305376.RA6mCu8FmG4UzXEK7S5qLt98SjuS3x_ghFAmC4n56ntyY130_provenance.
- NP305376.RA6mCu8FmG4UzXEK7S5qLt98SjuS3x_ghFAmC4n56ntyY130_assertion wasGeneratedBy ECO_0000203 NP305376.RA6mCu8FmG4UzXEK7S5qLt98SjuS3x_ghFAmC4n56ntyY130_provenance.